| pubmed-article:12667715 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C0004587 | lld:lifeskim |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C0085957 | lld:lifeskim |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C0021083 | lld:lifeskim |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C0544452 | lld:lifeskim |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C0023866 | lld:lifeskim |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C2825406 | lld:lifeskim |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C0549193 | lld:lifeskim |
| pubmed-article:12667715 | lifeskim:mentions | umls-concept:C0719214 | lld:lifeskim |
| pubmed-article:12667715 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:12667715 | pubmed:dateCreated | 2003-4-1 | lld:pubmed |
| pubmed-article:12667715 | pubmed:abstractText | To review prognostic factors identified in clinical trials for remission versus relapse after intravesical adjuvant Bacillus Calmette-Guérin (BCG) immunotherapy for superficial bladder cancer (Ta, T1, and carcinoma in situ). | lld:pubmed |
| pubmed-article:12667715 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12667715 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12667715 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12667715 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12667715 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12667715 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:12667715 | pubmed:issn | 0302-2838 | lld:pubmed |
| pubmed-article:12667715 | pubmed:author | pubmed-author:SaintFabienF | lld:pubmed |
| pubmed-article:12667715 | pubmed:author | pubmed-author:SalomonLauren... | lld:pubmed |
| pubmed-article:12667715 | pubmed:author | pubmed-author:AbbouClaude... | lld:pubmed |
| pubmed-article:12667715 | pubmed:author | pubmed-author:ChopinDominiq... | lld:pubmed |
| pubmed-article:12667715 | pubmed:author | pubmed-author:CiccoAntonyA | lld:pubmed |
| pubmed-article:12667715 | pubmed:author | pubmed-author:HoznekAndrasA | lld:pubmed |
| pubmed-article:12667715 | pubmed:author | pubmed-author:QuintelaRodri... | lld:pubmed |
| pubmed-article:12667715 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12667715 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:12667715 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12667715 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12667715 | pubmed:pagination | 351-60; discussion 360-1 | lld:pubmed |
| pubmed-article:12667715 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:meshHeading | pubmed-meshheading:12667715... | lld:pubmed |
| pubmed-article:12667715 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12667715 | pubmed:articleTitle | Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guérin (BCG) immunotherapy exist?. analysis of a quarter century of literature. | lld:pubmed |
| pubmed-article:12667715 | pubmed:affiliation | Urology Department, Groupe d'Etude des Tumeurs Urologiques (GETU), Hôpital Henri Mondor, 94000, Créteil, France. fabiensaint@hotmail.com | lld:pubmed |
| pubmed-article:12667715 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12667715 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:12667715 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12667715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12667715 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12667715 | lld:pubmed |
